Figures computed from official regulatory filings — .
Analysttarget 16.5 USD (+2%) · consensus 3.6/5 · 2 buy · 3 hold · 0 sell
Ownershipinsiders 0.39% · institutions 115.33% · short 26.8% of float
In USD · as of Oct 19, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for PERRIGO Co plc only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Market information source · Oct 19, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 19, 2026
Open-market timeline · full history
67 buys137 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Parker Geoffrey M.track record | Exercise | $17.3K | SEC |
| Alford Bradley A | Exercise | $17.3K | SEC |
| Alford Bradley A | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Parker Geoffrey M.track record | ExerciseD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Alford Bradley A | ExerciseD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Parker Geoffrey M.track record | Other | $8.3K | SEC |
| Alford Bradley A | Other | $8.3K | SEC |
| Ball David | Other | $39.9K | SEC |
| Ball David | Exercise | $110.4K | SEC |
| Ball David | ExerciseD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Manzone Albert | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Amin Ahmed Salman | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Gajial Muhammad Omer | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Khoury Roberto | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Ball David | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Willis Robert | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Lennox Abigail | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Bezerra Eduardo Guarita | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Atkinson Charles | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Winterman Matthew John | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Winterman Matthew John | Other | $10.1K | SEC |
| Khoury Roberto | Exercise | $7.8K | SEC |
| Khoury Roberto | ExerciseD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Winterman Matthew John | Exercise | $164.7K | SEC |
| Winterman Matthew John | ExerciseD (derivative) | n/a (No price was disclosed in the filing) | SEC |